| domain | biospace.com |
| summary | REGENXBIO CEO Ram Aiyar is in San Francisco seeking partnerships and investment to address recent setbacks, including an FDA-placed hold on their gene therapies for Hurler and Hunter syndromes due to a patient tumor discovery. The FDA’s decision on the Hunter syndrome program is pending by February 8th. |
| title | BioSpace: Biotech, Pharmaceutical and Clinical Research News |
| description | BioSpace: Biotech, Pharmaceutical and Clinical Research News |
| keywords | read, january, tristan, february, disease, more, therapy, gene, obesity, insights, companies, career, trends, cell, will, biotech, news |
| upstreams |
|
| downstreams |
|
| nslookup | A 15.197.236.53 |
| created | 2025-08-05 |
| updated | 2026-02-02 |
| summarized | 2026-02-03 |
|
|